Bureau Veritas: Oddo BHF raises target price
(CercleFinance.com) - Oddo BHF confirms its 'outperform' rating on Bureau Veritas shares, while raising its target price for them from E33 to E35, to reflect good execution and solid prospects for 2025 (confirmed by those of SGS).
The analyst explains the market's negative reaction to the previous day's publication by high expectations, with margins only in line despite a remarkable FCF, and believes that the risk linked to a potential investment by Wendel continues to weigh in the near term.
Oddo BHF nevertheless remains positive on Bureau Veritas, in view of recurrent organic growth, a portfolio increasingly optimised towards growth segments, and a healthy balance sheet enabling an acceleration of M&A.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.
The analyst explains the market's negative reaction to the previous day's publication by high expectations, with margins only in line despite a remarkable FCF, and believes that the risk linked to a potential investment by Wendel continues to weigh in the near term.
Oddo BHF nevertheless remains positive on Bureau Veritas, in view of recurrent organic growth, a portfolio increasingly optimised towards growth segments, and a healthy balance sheet enabling an acceleration of M&A.
Copyright (c) 2025 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.